Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05531643 · ClinicalTrials.gov registry record · NA
Pilot Study of TENS for Ocular Pain
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT05531643: Completed NA study, sponsored by VA Office of Research and Development.
NCT05531643 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05531643, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
Approximately 20% of Veterans have a diagnosis of dry eye (DE) syndrome which is often accompanied by ocular pain that significantly impacts activities of daily living. Currently very few treatments are available for chronic ocular pain, likely because the mechanisms underlying this type of pain have only recently begun to be studied. New treatments that target the neuropathic mechanisms contributing to this type of pain are needed. The proposed research provides a crucial step in addressing the lack of treatments for neuropathic ocular pain by validating the methodology needed to support a randomized controlled trial of transcutaneous electrical nerve stimulation (TENS). TENS is a non-pharmacologic, non-addictive, non-invasive treatment that has been shown to be effective in other chronic pain conditions. The present pilot study aims to address the need for preliminary support of safety and efficacy of TENS for ocular pain, t to advance the study of new treatments for the long-term relief of chronic ocular pain and its impact on health.
Interventions
- DEVICE High frequency forehead TENS
- DEVICE Low frequency forehead TENS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2022-10-03 |
| Est. Completion | 2024-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05531643
The ClinicalTrials.gov registry entry for NCT05531643 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which High frequency forehead TENS is the first listed.
NCT05531643 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05531643 about?
NCT05531643 is a clinical study titled "Pilot Study of TENS for Ocular Pain". Approximately 20% of Veterans have a diagnosis of dry eye (DE) syndrome which is often accompanied by ocular pain that significantly impacts activities of daily living. Currently very few treatments are available for chronic ocular pain, likely because the mechanisms underlying this type of pain hav...
What is the current status of trial NCT05531643?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2022-10-03. Estimated completion is 2024-11-30.
What interventions are being tested in trial NCT05531643?
The interventions under investigation include: High frequency forehead TENS (DEVICE), Low frequency forehead TENS (DEVICE).
Who is sponsoring clinical trial NCT05531643?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.